Navigation Links
Immunomedics Announces Preclinical Therapy Results of SN-38 Immunoconjugate for Colorectal Cancer
Date:1/20/2009

s. For additional information on us, please visit our website at www.immunomedics.com. The information on our website does not, however, form a part of this press release.

This release, in addition to historical information, may contain forward-looking statements made pursuant to the Private Securities Litigation Reform Act of 1995. Such statements, including statements regarding clinical trials, out-licensing arrangements (including the timing and amount of contingent payments), forecasts of future operating results, and capital raising activities, involve significant risks and uncertainties and actual results could differ materially from those expressed or implied herein. Factors that could cause such differences include, but are not limited to, risks associated with new product development (including clinical trials outcome and regulatory requirements/actions), our dependence on our licensing partners for the further development of epratuzumab for autoimmune indications and veltuzumab for non-cancer indications, competitive risks to marketed products and availability of required financing and other sources of funds on acceptable terms, if at all, as well as the risks discussed in the Company's filings with the Securities and Exchange Commission. The Company is not under any obligation, and the Company expressly disclaims any obligation, to update or alter any forward-looking statements, whether as a result of new information, future events or otherwise.

    For More Information:
    Dr. Chau Cheng
    Associate Director, Investor Relations & Business Analysis
    (973) 605-8200, extension 123
    ccheng@immunomedics.com

'/>"/>
SOURCE Immunomedics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
2. Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinsons Disease Drug KW-6002 (Istradefylline)
3. Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
4. Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
5. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
6. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
7. Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse
8. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
9. Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
10. ProUroCare Medical Inc. Announces Pricing of Equity Offering
11. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... BURLINGTON, Mass. , Aug. 21, 2014 /PRNewswire/ ... of COPD,  physicians in Brazil ... to follow clinical guidelines and commonly prescribe long-acting ... regimens, although they do so within current severe ... combinations (FDCs) that are expected to launch in ...
(Date:8/21/2014)... Aug. 21, 2014 /PRNewswire-iReach/ -- ScriptPro has been ... under its Common Security Framework (CSF). According to ... Privacy Manager, "We appreciate this rigorous, top-to-bottom audit. ... that this certification signifies. Our business partners need ... THE CSF CERTIFICATION PROCESS: ScriptPro,s internal security processes ...
(Date:8/21/2014)... BreedIT Corp., (OTCQB: BRDT) ... worldwide license holder and distributor of highly sophisticated ... today is pleased to announce the formation of ... a leading Israeli medical Cannabis breeder. ... breeds of medical Cannabis to meet the requests ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3ScriptPro Achieves HITRUST Certification 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4
... SAN DIEGO, Jan. 11 CareFusion (NYSE: CFN ... the Food and Drug Administration (FDA) has given the company ... SE line of infusion pumps (also known as the Signature ... Medical Products division of Cardinal Health, has been operating under ...
... , PRINCETON, N.J., Jan. 11 Covance ... present at the 28th Annual J.P. Morgan Healthcare Conference on Wednesday, ... a live webcast of the presentation at www.covance.com . ... on 10 minutes early. , Covance, with headquarters in Princeton, New ...
Cached Medicine Technology:FDA Lifts Injunction on Manufacture and Sale of CareFusion Alaris(R) SE Pump 2
(Date:8/22/2014)... Drug and alcohol addiction is ... abuse has claimed thousands of lives throughout the region. ... hope for teenagers who are seeking to overcome their ... to provide adolescents and their parents with guidance, support ... youth rehab facility to meet their specific needs. ...
(Date:8/22/2014)... Mission Hills, CA (PRWEB) August 22, 2014 ... Line Personal for this snoring cure. , In the October ... an interview of Dr Grossan about his method of treating ... The article quotes Dr Grossan: "Nearly half of all adults ... they’re sleeping. This is because air passages in the ...
(Date:8/22/2014)... 2014 According to the market ... Adaptive Cruise Control (ACC) System Market for Passenger ... - 2019", published by MarketsandMarkets, classifies and defines ... terms of volume and value. The report highlights ... well as covers review of the market drivers, ...
(Date:8/21/2014)... August 22, 2014 Benefiting from ... for medical expenses, the Chinese orthopedic instrument market ... presenting a CAGR of 19.2% during 2009-2013. Trauma ... product segments of orthopedic instruments in China, of ... market share in 2013. , Being optimistic about ...
(Date:8/21/2014)... Island, New York (PRWEB) August 22, 2014 ... education for the Long Island region, proudly announces the ... new site, focused on the West Babylon-based yoga studio’s ... enthusiasts who wish to become teachers realize their dreams. ... Babylon community and those living in the surrounding area ...
Breaking Medicine News(10 mins):Health News:Substance Abuse Helpline Provides Hope for Teens & Parents in Brunswick, OH 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 2Health News:Dr Murray Grossan Explains how and why Singing Exercises Stop Snoring 3Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 2Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 3Health News:Automotive Blind Spot Detection System Market Worth $2.8 Billion and Automotive Adaptive Cruise Control System Market Worth $6.1 Billion by 2019 – New Report 4Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 2Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 3Health News:China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com 4Health News:Yoga Darshana Center Announces Launch of New Website LongIslandYogaTeacherTraining.com 2
... for new mothers, according to a study in the ... researcher Dr. Robert Whitaker. , While smoking and ... also affect the health of her child, Whitaker said. ... smoking include sudden infant death, asthma, ear infections and ...
... awareness of Molluscum Contagiosum, CHARLES TOWN, W.V., ... RBRM) a provider of treatment for diabetic,peripheral neuropathy ... the month of October 2007; increase is 12% ... "As public awareness of the dangers related ...
... YORK, Nov. 26 /Xinhua-PRNewswire-FirstCall/ -- itLinkz Group, Inc.,("ILKZ") ... beginning of,trading today, November 26, 2007, the Company ... Inc." and began trading under its new,symbol (OTC ... a,1:28 reverse split of its outstanding common shares ...
... Giesing, Chief Scientific,Officer and Terry Nida, Chief Operating ... (http://www.urigen.com ) will be featured in an,exclusive ... 27 at 10:30,a.m. EST. The interview will be ... EST on,November 27., The interview will cover ...
... 26, 2007) Rutgers College of Nursing faculty member ... of the Rutgers-Newark Provosts Award for Community Engagement in ... significance based in whole or in part on data ... Diner, Rutgers-Newark provost, established the Provosts Awards for Community ...
... technology allows medical professionals to instantly ... access and manipulate ... a global leader in,software-driven systems for targeted, less-invasive medical ... at the,Annual Meeting of the Radiological Society of North ...
Cached Medicine News:Health News:Smoking and depression often co-occur in new mothers 2Health News:ReBuilder Medical Technologies, Inc. Announces Record Sales Month 2Health News:itLinkz Group, Inc. Changes Name to China YCT International Group, Inc. and Effects Reverse Stock Split 2Health News:WallSt.net Announces Upcoming Interview with CSO and COO of Urigen Pharmaceuticals 2Health News:Rutgers College of Nursing faculty member Rachel Jones awarded Rutgers-Newark Provost Award 2Health News:Digital Lightbox(C) Unlocks New Possibilities in Collaborative Patient Treatment 2Health News:Digital Lightbox(C) Unlocks New Possibilities in Collaborative Patient Treatment 3
The lower body blanket is designed to be used primarily during surgery on the upper half of the body....
This blanket is ideal for warming the large child or small adult during upper body surgery....
The torso blanket is designed to affix to the lower abdominal area and cover the upper half of the body....
The fabric is antistatic and non-linting and is both oil and water repellent.These superior blankets are an environmental friendly alternative to disposable blankets....
Medicine Products: